Serum sickness following rabbit antithymocyte-globulin induction in a liver transplant recipient: Case report and literature review

Liver Transplantation

Volumn 13, Issue 5, 2007, Pages 647-650

  Lundquist, Andrew L ^a   Chari, Ravi S ^a,b   Wood, James H ^a   Miller, Geraldine G ^a   Schaefer, Heidi M ^a   Raiford, David S ^a   Wright, Kelly J ^a   Gorden, D Lee ^a,b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Division of Hepatobiliary Surgery and Liver Transplantation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CALCINEURIN INHIBITOR; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CREATININE; DIGLYCINE; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ADULT; ARTHRALGIA; ARTICLE; ASCITES; BACTERIAL PERITONITIS; BILIARY TRACT SCINTISCANNING; CASE REPORT; DIAGNOSTIC PROCEDURE; DRUG FEVER; DRUG USE; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; GRAFT RECIPIENT; GRAFT REJECTION; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; KIDNEY DISEASE; LEUKOCYTOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MORBIDITY; PARACENTESIS; PLASMAPHERESIS; PRIORITY JOURNAL; SERUM SICKNESS; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, MONOCLONAL; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE, ACUTE; LIVER TRANSPLANTATION; METHYLPREDNISOLONE; MIDDLE AGED; RABBITS; SERUM SICKNESS; TREATMENT OUTCOME;

EID: 34249083437     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21098     Document Type: Article

References (22)

1. Fung J, Kelly D, Kadry Z, Patel-Tom K, Eghtesad B. Immunosuppression in liver transplantation: beyond calcineurin inhibitors. Liver Transpl 2005;11:267-280.
2. Stegall MD, Everson G, Schroter G, Bilir B, Karrer F, Kam I. Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. Transplantation 1995;60:1057-1060.
3. Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM, Levy MF, Klintmalm GB. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment. Transplantation 2001;72:1934-1939.
4. Jain AB, Yee LD, Nalesnik MA, Youk A, Marsh G, Reyes J, Zak M, et al. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998;66;1193-1200.
5. Bourdage JS, Hamlin DM. Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry. Transplantation 1995;59:1194-1200.
6. Starzl TE, Marchioro TL, Hutchinson DE, Porter KA, Cerilli GJ, Brettschneider L. The clinical use of antilymphocyte globulin in renal homotransplantation. Transplantation 1967;5(4)Suppl:1100-1105.
7. Storb R, Gluckman E, Thomas ED, Buckner CD, Clift RA, Fefer A, et al. Treatment of established human graft-versus-host disease by antithymocyte globulin. Blood 1974; 44:56-75.
8. Marsh J, Schrezenmeier H, Marin P, Ilhan O, Ljungman P, McCann S, et al. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaernia Working Party. Blood 1999;93: 2191-2195.
9. Tector AJ, Fridell JA, Mangus RS, Shah A, Milgrom M, Kwo P, et al. Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients. Liver Transpl 2004;10:404-407.
10. Tchervenkov JI, Tzimas GN, Cantarovich M, Barkun JS, Metrakos P. The impact of thymoglobutin on renal function and calcineurin inhibitor initiation in recipients of orthotopic liver transplant: a retrospective analysis of 298 consecutive patients. Transplant Proc 2004;36:1747-1752.
11. Eason JD, Loss GE, Blazek J, Nair S, Mason AL. Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial. Liver Transpl 2001;7:693-697.
12. Starzl TE, Murase N, Abu-Elmagd K, Gray EA, Shapiro R, Eghtesad B, et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003;361:1502-1510.
13. Buchler M, Hurault de LB, Madec C, Lebranchu Y. Induction therapy by anti-thymocyte globulin (rabbit) in renal transplantation: a 1-yr follow-up of safety and efficacy. Clin Transplant 2003;17:539-545.
14. Kamar N, Ribes D, Sandres-Saune K, Suc B, Barange K, Cointault O, et al. Efficacy and safety of induction therapy with rabbit antithymocyte globulins in liver transplantation for hepatitis C. Transplant Proc 2004;36:2757-2761.
15. Tanriover B, Chuang P, Fishbach B, Helderman JH, Kizilisik T, Nylander W, et al. Polyclonal antibody-induced serum sickness in renal transplant recipients: treatment with therapeutic plasma exchange. Transplantation 2005; 80:279-281.
16. Bielory L, Gascon P, Lawley TJ, Young NS, Frank MM. Human serum sickness: a prospective analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure. Medicine (Baltimore) 1988;67:40-57.
17. Christiaans MH, van Hooff JP. Plasmapheresis and RATG-induced serum sickness. Transplantation 2006;81:296.
18. Mourad G, Garrigue V, Squifflet JP, Besse T, Berthoux F, Alamartine E, et al. Induction versus noninduction in renal transplant recipients with tacrolimus-based immuno-suppression. Transplantation 2001;72:1050-1055.
19. Charpentier B, Rostaing L, Berthoux F, Lang P, Civati G, Touraine JL, et al. A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients. Transplantation 2003;75:844-851.
20. Ault BH, Honaker MR, Gaber AO, Jones DP, Duhart BT, Powell SL, et al. Short-term outcomes of thymoglobulin induction in pediatric renal transplant recipients. Pediatr Nephrol 2002; 17:815-818.
21. Di Fillippo S, Boissonnat P, Sassolas F, Robin J, Ninet J, Champsaur G, Bozio A. Rabbit antithymocyte globulin as induction immunotherapy in pediatric heart transplantation. Transplantation 2003;75:354-358.
22. Bogetti D, Sankary HN, Jarzembowski TM, Manzelli A, Knight PS, Thielke J, et al. Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury. Clin Transplant 2005; 19:507-511.